Skip to main content
SpringerLink
Log in

The role of fibrinolysis in vascular diseases in UK biobank

  • Letter to the Editor
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tada H, Fujino N, Hayashi K, Kawashiri MA, Takamura M (2022) Human genetics and its impact on cardiovascular disease. J Cardiol 79:233–239. https://doi.org/10.1016/j.jjcc.2021.09.005

    Article  PubMed  Google Scholar 

  2. Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, McMahon A, Morales J, Mountjoy E, Sollis E, Suveges D, Vrousgou O, Whetzel PL, Amode R, Guillen JA, Riat HS, Trevanion SJ, Hall P, Junkins H, Flicek P, Burdett T, Hindorff LA, Cunningham F, Parkinson H (2019) The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res 47:D1005–D1012. https://doi.org/10.1093/nar/gky1120

    Article  CAS  PubMed  Google Scholar 

  3. Kietsiriroje N, Ariëns RAS, Ajjan RA (2021) Fibrinolysis in Acute and Chronic Cardiovascular Disease. Semin Thromb Hemost 47:490–505. https://doi.org/10.1055/s-0040-1718923

    Article  CAS  PubMed  Google Scholar 

  4. Undas A (2021) Fibrinolysis in venous thromboembolism. Semin Thromb Hemost 47:480–489. https://doi.org/10.1055/s-0041-1725094

    Article  CAS  PubMed  Google Scholar 

  5. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419–424. https://doi.org/10.1038/368419a0

    Article  CAS  PubMed  Google Scholar 

  6. Erickson LA, Fici GJ, Lund JE, Boyle TP, Polites HG, Marotti KR (1990) Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature 346:74–76. https://doi.org/10.1038/346074a0

    Article  CAS  PubMed  Google Scholar 

  7. Altaf F, Wu S, Kasim V (2021) Role of fibrinolytic enzymes in Anti-Thrombosis Therapy. Front Mol Biosci 8:680397. https://doi.org/10.3389/fmolb.2021.680397

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Zöller B, Svensson PJ, Dahlbäck B, Lind-Hallden C, Hallden C, Elf J (2020) Genetic risk factors for venous thromboembolism. Expert Rev Hematol 13:971–981. https://doi.org/10.1080/17474086.2020.1804354

    Article  CAS  PubMed  Google Scholar 

  9. Celkan T (2017) Plasminogen deficiency. J Thromb Thrombolysis 43:132–138. https://doi.org/10.1007/s11239-016-1416-6

    Article  CAS  PubMed  Google Scholar 

  10. Wang Q, Dhindsa RS, Carss K, Harper AR, Nag A, Tachmazidou I, Vitsios D, Deevi SVV, Mackay A, Muthas D, Hühn M, Monkley S, Olsson H, AstraZeneca G, Wasilewski I, Smith S, March KR, Platt R, Haefliger A, Petrovski C (2021) Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature 597:527–532. https://doi.org/10.1038/s41586-021-03855-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Karczewski KJ, Solomonson M, Chao KR et al (2022) Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes. Cell Genomics 2. https://doi.org/10.1016/j.xgen.2022.100168

  12. Yeung MW, Wang S, van de Vegte YJ, Borisov O, van Setten J, Snieder H, Verweij N, Said MA, van der Harst P (2022) Twenty-five novel loci for carotid intima-media thickness: a genome-wide Association study in > 45 000 individuals and Meta-analysis of > 100 000 individuals. Arterioscler Thromb Vasc Biol 42:484–501. https://doi.org/10.1161/ATVBAHA.121.317007

    Article  CAS  PubMed  Google Scholar 

  13. Jovin IS, Müller-Berghaus G (2004) Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis. Atherosclerosis 174:225–233. https://doi.org/10.1016/j.atherosclerosis.2004.01.026

    Article  CAS  PubMed  Google Scholar 

  14. Meltzer ME, Bol L, Rosendaal FR, Lisman T, Cannegieter SC (2010) Hypofibrinolysis as a risk factor for recurrent venous thrombosis; results of the LETS follow-up study. J Thromb Haemost 8:605–607. https://doi.org/10.1111/j.1538-7836.2009.03715.x

    Article  CAS  PubMed  Google Scholar 

  15. Sundquist K, Wang X, Svensson PJ, Sundquist J, Hedelius A, Larsson Lönn S, Zöller B, Memon AA (2015) Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence. Thromb Haemost 114:1156–1164. https://doi.org/10.1160/TH15-01-0031

    Article  PubMed  Google Scholar 

  16. Mukhopadhyay S, Johnson TA, Sarkar R, Antalis TM (2018) Serpins in venous thrombosis and venous Thrombus resolution. Methods Mol Biol 1826:197–211. https://doi.org/10.1007/978-1-4939-8645-3_13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Patrick Reilly, science editor at Centre for Primary Health Care Research, Department of Clinical Science, Lund University and Region Skåne, Malmö, Sweden, for language review. We acknowledge the free access to the Astra Zeneca and Genebass portals that made this work possible (https://azphewas.com/ and https://app.genebass.org/). This work was supported by a grant awarded to Dr Bengt Zöller by ALF-funding from Region Skåne, Sparbanken Skåne, and by the Swedish Research Council.

Author information

Authors and Affiliations

  1. Center for Primary Health Care Research, Department of Clinical Sciences, Lund University and Region Skåne, CRC, Building 28, Floor 11 Jan Waldenströms gata 35, Malmö, Sweden

    Bengt Zöller, Eric Manderstedt & Christer Halldén

  2. Department of Environmental Science and Bioscience, Kristianstad University, Kristianstad, Sweden

    Christina Lind-Halldén

Authors
  1. Bengt Zöller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Manderstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christina Lind-Halldén
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christer Halldén
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bengt Zöller.

Ethics declarations

Competing interests

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zöller, B., Manderstedt, E., Lind-Halldén, C. et al. The role of fibrinolysis in vascular diseases in UK biobank. J Thromb Thrombolysis 56, 635–638 (2023). https://doi.org/10.1007/s11239-023-02876-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-023-02876-w

Keywords

Search

Navigation